Shilpa Medicare Limited Share Price & Technical Analysis
SHILPAMED · ₹525.8 (+2.02%)
Healthcare / Drug Manufacturers - Specialty & Generic
₹525.8
+2.02%
Shilpa Medicare Limited, together with its subsidiaries, manufactures and sells active pharmaceutical ingredients (APIs), finished dosage formulations, biosimilars, and contract development and manufacturing organisation in India, the United States, Europe, and internationally. The company offers various oncology and non-oncology APIs, such as anastrozole, acebrophylline, ambroxol hydrochloride, a…
Price chart
Seasonality
Jun has 3 positive and 2 negative years (last 5 years shown)
4% return in Jun, 11% avg return in past 3 year Jun month.
58% return in 2026, 32% avg return in past 3 years.
Swipe sideways to see all months →
| Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec | Yr | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 26 | -10% | 17% | 10% | 13% | 23% | 4% | – | – | – | – | – | – | 58% |
| 25 | -13% | -12% | 7% | -2% | 40% | -1% | -1% | -4% | -11% | -7% | -4% | -6% | -16% |
| 24 | 12% | 14% | 10% | 19% | -12% | 14% | 20% | 12% | 6% | 4% | 6% | -11% | 93% |
| 23 | -12% | 4% | -11% | 11% | -7% | 19% | 24% | 3% | -3% | -2% | 3% | -10% | 19% |
| 22 | -6% | -20% | -2% | 15% | -5% | -9% | 6% | -6% | -1% | -18% | -11% | -8% | -65% |
Monthly return % by calendar month · historical pattern, not a forecast
Neutral · Strong · Strong
Shilpa Medicare Limited, together with its subsidiaries, manufactures and sells active pharmaceutical ingredients (APIs), finished dosage formulations, biosimilars, and contract development and manufacturing organisation in India, the United States, Europe, and internationally. The company offers various oncology and non-oncology APIs, such as anastrozole, acebrophylline, ambroxol hydrochloride, axitinib, azacitidine, abiraterone acetate, bendamustine HCL monohydrate, bicalutamide, bortezomib, busulphan, cabazitaxel amorphous, capecitabine, clofarabine, cyclophosphamide, dasatinib, decitabine, dimethyl fumarate, erlotinib HCL, enzalutamide, fingolimod hydrochloride, gemcitabine HCl, ibrutinib, imatinib mesylate, irinotecan HCl trihydrate, lenalidomide, lenvatinib mesylate, letrozole, and melphalan HCL. It also provides nifedipine, oxaliplatin, pazopanib, pemetrexed disodium hemipentahydrate, pemetrexed dipotassium nonahydrate, pirfenidone, pomalidomide, sodium cholesteryl sulfate, sorafenib tosylate, sunitinib malate, temozolomide, teriflunomide, thalidomide, tranexamic and zoledronic acid, phenylephrine, citicholine, palbocicilib, nilotinib, nintedanib, praziquintol, carmustine, elthrombopag olamine, abacavir sulphate, tenofovir disproxyl fumarate API, tenofovir alfanamide, prucalopride succinate, and varenicline tartrate. In addition, the company offers intermediates; peptides; biopolymers; biologics; contract development and manufacturing services; and formulations, such as tablets, capsules, liquid injections, dry powder injectable products, oral dissolving films, transdermal patches. Further, it is involved in the manufacture of specialized oncology formulations; and wind power generation activities. The company was formerly known as Shilpa Antibiotics Ltd and changed its name to Shilpa Medicare Limited in February 2003. Shilpa Medicare Limited was incorporated in 1987 and is based in Raichur, India.
Full AI Q&A, portfolio tracking, and live alerts in the app.
Key metrics
Market cap
₹101.18B
P/E ratio
41.62
52W high
₹532.2
52W low
₹259.5
Volume
13,16,005
Beta
0.14
Related stocks in Healthcare
Ngl Fine-chem Ltd.
₹2,732
Frequently asked questions
- What is Shilpa Medicare Limited share price today?
- Shilpa Medicare Limited (SHILPAMED) last traded around ₹525.8 on StockPro. Prices refresh every few minutes during market hours.
- What technical signals does SHILPAMED have?
- StockPro currently tracks 1 active signal(s) for SHILPAMED, including breakouts, momentum, and volume patterns. See the signals panel on this page.
- How can I analyze Shilpa Medicare Limited stock?
- Use the price chart, seasonality heatmap, key metrics, and AI insight on this page. For portfolio tracking and push alerts, download StockPro on Android or iOS.